Mondego Bio Secures Series A Funding for Immuno-Oncology Development

Snell & Wilmer has advised Mondego Bio on the transaction. Mondego Bio Lda, an immuno-oncology company based in Lisbon, has emerged from stealth mode with the…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here